Combination of novel proteasome inhibitor NPI-0052 and lenalidomide trigger in vitro and in vivo synergistic cytotoxicity in multiple myeloma.

Source:http://linkedlifedata.com/resource/pubmed/id/19965674

Blood 2010 Jan 28 115 4 834-45

Download in:

View as

Triples

General Info

PMID
19965674